Baxter acquires PerClot assets from CryoLife
The acquisition advances Baxter’s surgery portfolio to include a wider range of active and passive solutions.
News
Cepheid’s two HIV-1 tests obtain CE-IVD clearance
Cepheid plans to start shipping the HIV test kits to CE mark-accepting countries by the...
Abbott launches insertable cardiac monitor for abnormal heart rhythms
Jot Dx ICM aids in identifying cardiac arrhythmia remotely and boosts the accuracy of diagnosis.
Thermo Fisher reports 34% growth in Q2 2021 revenue
For this year, Thermo Fisher raises revenue guidance by $300m to $35.9bn, which would result...
Orthofix Medical launches fibre bone-graft solution
To enable optimised application for posterior cervical procedures, fiberFUSE is formulated as a preformed bone-graft...
FDA approves Medtronic’s AI algorithms for cardiac monitoring
The AI algorithms lower AF and asystole false alerts provided by the LINQ II insertable cardiac monitor.
Boston Scientific reports 53.6% rise in net sales for Q2 2021
Boston Scientific issued full year 2021 guidance, which reflects net sales growth of 21-22% on a reported basis.
MeMed obtains CE mark for Covid-19 tool
MeMed COVID-19 Severity uses machine learning to determine the risk of severe outcomes in patients.
BD acquires resorbable polymer technology maker Tepha
BD will leverage Tepha’s technology to develop surgical meshes for the repair and regeneration of soft tissues.
PerkinElmer agrees to acquire antibody maker BioLegend for $5.25bn
On acquisition, BioLegend’s campus in San Diego will be turned into PerkinElmer’s CoE to develop reagent content.
Philips reports 9% comparable sales growth in Q2 2021
Philips is set to start a share buyback programme, for capital reduction purposes, totalling up to $1.7bn.
